Stock markets move lower on U.S.-China trade concerns; C$ dollar, commodities fall

By Malcolm Morrison, The Canadian Press

TORONTO - The Toronto stock market moved lower Monday alongside other markets around the world amid trade tensions between China and the United States.

The S&P/TSX composite index lost 51.2 points to 11,202 after rising just over two per cent last week.

Concerns about a growing trade dispute rose as the Chinese government filed a World Trade Organization complaint over new U.S. tariffs on Chinese tires.

President Barack Obama approved the higher duties to slow the rapid growth of U.S. imports of Chinese-made tires blamed for the loss of thousands of American jobs. Beijing criticized the move as a violation of free trade and called on other governments to oppose protectionism.

On Sunday, Beijing announced it would investigate complaints that American auto and chicken products are being dumped in China or benefit from subsidies, saying the U.S. imports have "dealt a blow to domestic industries."

The TSX energy sector was a major drag, down 0.63 per cent as a stronger U.S. dollar pulled down commodity prices and made a dent in the Canadian dollar.

The loonie moved down 0.92 of a cent to 91.79 cents US.

The October crude contract on the New York Mercantile Exchange moved down 59 cents to US$68.70 a barrel. Suncor Inc. (TSX: SU.TO) dropped 38 cents to $36.34.

The December bullion contract on the New York Mercantile Exchange lost $6.10 to US$1000.30 an ounce, taking the gold sector down 0.33 per cent. The base metals sector was down 1.38 per cent as December copper moved down six cents to US$2.79 a pound.

The TSX Venture Exchange moved 4.67 points lower to 1,257.22.

The Dow Jones industrial average declined 63.2 points to 9,542.2 after gaining 1.73 per cent last week.

The Nasdaq composite index lost 9.99 points to 2,070.91 while the S&P 500 index fell 6.3 points to 1,036.45.

Obama will also be the centre of attention as he gives a speech on the one-year anniversary of the collapse of Lehman Brothers Holdings Inc., which helped spark the worst period of the financial crisis and credit crunch. The president will discuss the actions the U.S. government has taken to help the economy and stabilize the financial sector as well as further regulation needed to help avoid a future collapse during a speech in New York.

In economic news, Statistics Canada said the rate of capacity utilization in Canadian industries continued to shrink in the second quarter. Industrial capacity came in at 67.4 per cent for the period, down 2.8 percentage points from the first quarter and a much better showing than the 65.5 per cent reading that economists had expected.

Statistics Canada noted that the second quarter figure is still the lowest level since it started gathering this information in 1987.

Investors will be looking at two major pieces of economic news during the week.

Manufacturing shipments data comes out Wednesday and is expected to show a 2.5 per cent gain during July.

The key data for the week is the consumer price index report which is being released on Thursday. Economists are looking for year on year growth of 1.6 per cent.

In the U.S., investors will have little in the way of economic news Monday to provide further insight into a potential economic recovery. However, reports on inflation, retail sales, industrial product and housing starts are due out later in the week.

In corporate news, Allen Vanguard Inc. (TSX: VRS.TO), a financially troubled Ottawa-based maker of bomb disposal technology, has been acquired by U.S. private equity firm Versa Capital Management Inc. The deal also recapitalizes the company and keeps it operating, but wipes out the value held by current shareholders. Financial terms were not revealed and its shares have been suspended from trading on the TSX, where they closed at 10 cents on Friday.

Drugmaker Patheon (TSX: PTI.TO) reported Monday a "disappointing" third-quarter as revenues plunged 15.7 per cent due to due to setbacks at its Puerto Rico operations, a slowdown in its pharmaceutical development services and a drop in the U.S. dollar, among other factors. Its shares were unchanged at $2.99.

The Toronto-based company, which had been at the centre of a takeover battle, said its net loss for the quarter ended July 31 was $6 million, 10.6 cents per share, compared with a loss of $14 million, 15.4 cents per share, in the year-earlier period.

Overseas, Japan's Nikkei stock average fell 2.3 per cent while Hong Kong's Hang Seng closed down 1.1 per cent.

In afternoon trading, Britain's FTSE 100 declined 0.61 per cent, Germany's DAX index fell 0.95 per cent, and France's CAC-40 dropped one per cent.